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Abstract The Phenomenex EZ:faast
TM amino acid anal-
ysis kit is available for gas (GC) or liquid (LC)
chromatographic analysis of amino acids (AA) using mass
spectrometry (MS) and other GC detectors. We used it for
rapid GC determination of plasma tryptophan, its brain
uptake competitors (Val, Leu, Ile, Phe and Tyr) and many
other amino acids. Based on solid-phase extraction, this fast
methodenablesonepersontoprocesstwoplasmasamplesin
8–10 min and six samples in *15 min up to GC injection
and a 7-min GC run per plasma sample. Using a Perkin-
Elmer Clarus 500 GC, a Total Chrome software, a ﬂame-
ionisation detector (FID) and norvaline as internal standard,
we used this method to analyse *1,000 plasma samples
fromnormalsubjectsundergoingacutetryptophandepletion
andloadingtests.Thelimitofdetectionformostaminoacids
is 1 nmol/ml (1 lM) and in many cases less. With manual
injection, coefﬁcients of variation for the above six amino
acids were 1.5–6.2% (intra-assay) and 3.8–9.7% (inter-
assay). This simple, rapid and elegant method will be valu-
able to the amino acid analyst and researcher, as it can save
much manpower time and meet urgent emergency requests
and the demands of a high-throughput laboratory.
Keywords Analysis  EZ:faast  Gas chromatography 
Isoleucine  Leucine  Phenylalanine  Tryptophan 
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Introduction
Amino acid (AA) analysis in biological ﬂuids is an
important laboratory test in the diagnosis of inherited dis-
orders of AA metabolism, the monitoring of bone and
muscle disorders and of patients requiring long-term
nutritional support, evaluation of new baby milks and
parenteral and enteral feeds, and detection of renal drug
toxicity (for a review, see Walker and Mills 1995). In
psychopharmacological research and practice, the moni-
toring of tryptophan, and other aromatic and branched-
chain AA (BCAA) under basal conditions and following
the acute tryptophan depletion (or loading) test (Young
et al. 1985; Reilly et al. 1997) is a vital research and
diagnostic tool for assessing the role of the brain indolyl-
amine 5-hydroxytryptamine (5-HT or serotonin) in mood
and other behavioural disorders. Walker and Mills (1995)
examined many of the problems encountered with the
various AA analytical procedures. One such problem is the
relatively long time required for sample preparation and
analysis. Sample preparation requires protein precipitation,
removal of interfering substances and derivatisation, all of
which combine to cause a signiﬁcant time delay before
analysis. Furthermore, analysis time with the commonly
used existing techniques varies between 2 and 4 h with
cation-exchange-based dedicated AA auto-analysers and
up to 1 h with high-performance liquid chromatography
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DOI 10.1007/s00726-007-0012-7(HPLC; Walker and Mills 1995). Even with the faster mass
spectrometry (MS), time (up to 40 min) has still to be spent
on deproteinisation of samples.
A method that considerably overcomes the above time
delays is the use of the Phenomenex EZ:faast
TM family of
amino acid analysis kits (Phenomenex EZ:faast [easy fast]
amino acid sample testing kit 2003), which utilise gas
chromatography(GC)withﬂameionisation(FID),nitrogen-
phosphorus (NPD) or mass spectrometric (GC-MS) detec-
tion or liquid chromatography (LC-MS). The kit for LC-MS
can measure at least 50 amino acids and their derivatives,
includingthevarioussulphurandureacycleAA,whereasthe
GC kits do not measure arginine, cysteine, citrulline, 1- and
3-methylhistidines and taurine. Faced with the need to ana-
lyse a large number of plasma samples obtained from
subjects undergoing acute tryptophan depletion and loading
tests,wesuccessfullyappliedtheabovekitforanalysisofthe
relevant plasma AA using GC-FID. Based on solid-phase
extraction (SPE), this simple, elegant and thus far the most
rapid method will be invaluable to AA analysts and
researchers and will meet emergency requirements and the
needs of high throughput clinical laboratories. A brief
account of a part of this work has appeared in the abstract
form(Badawyetal.2005)andexperimentaldataconcerning
the speciﬁcity of the acute Trp depletion and loading tests
using this method are already in press (Badawy et al. 2007).
Materials and methods
Amino acids and other chemicals
Amino acids were purchased from the Sigma-Aldrich Co.
Ltd. (Fancy Road, Poole, Dorset, BH12 4QH, UK), whereas
all other laboratory reagents were from VWR International
Ltd. (Hunter Boulevard, Magna Park, Leicestershire LE17
4XN, UK) and were of the purest commercially available
grades. For HPLC experiments, the relevant (HPLC) grade
chemicals were used when commercially available.
Kit components and other material
These are listed in Table 1. Other materials required, but
not supplied in the kit, were: (1) 100 lL–1 mL pipette; (2)
30–300 lL pipette; (3) pipette tips; (4) vortex; (5) vials of
appropriate volumes with caps; (6) Pasteur pipettes for sample
transfer; (7) container for proper waste disposal; (8) septa.
Reagents 2, 3A, 5 and 6 should be stored at room
temperature, whereas reagents 1, 3B and 4 should be stored
at 4C. The 3 Phenomenex standards should all be stored in
a freezer. If stored under these conditions, all these
reagents would have a shelf life of 1 year.
The Phenomenex standards 1, 2 and 3
Standards 1 and 2 are mixtures of most amino acids
occurring in plasma and were used throughout this work,
whereas Standard 3 was not used, as it contains the six
urine-speciﬁc components: a-aminopimelic acid, cystathi-
onine, glycine-proline dipeptide, hydroxylysine, proline-
hydroxyproline dipeptide and thioproline. Standard 2
contains only the 3 amino acids, which are unstable in acid
solution, namely asparagine, glutamine and tryptophan,
whereas Standard 1 contains 23 other amino acids.
Preparation of the elution medium
The elution medium (200 lL per sample) should be pre-
pared freshly on the day of the experiment, in economical
amounts, depending on the total number of samples to be
analysed, by mixing three parts of Reagent 3A with two
parts of Reagent 3B in a capped vial of appropriate size.
Table 1 Components of the EZ:faast
TM GC-FID amino acid analysis
kit
Components Name/detail Capacity/number
A: Reagents
Reagent 1 Internal standard
solution
50 mL
Reagent 2 Washing solution 90 mL
Reagent 3A Elution medium
component 1
60 mL
Reagent 3B Elution medium
component 2
40 mL
Reagent 4 Organic solution I Four vials, 6 mL@
Reagent 5 Organic solution
II
50 mL
Reagent 6 Acid solution 50 mL
Standards 1, 2 and 3 Amino acid
standard
mixture
Two vials of each
Standard, 2 mL@
B: Supplies
Sorbent tips in racks 4 9 96
Sample preparation vials 4 9 100
Vial rack 1
Microdispenser,
20–100 lL
1
Syringes, 0.6 mL and
1.5 mL
10 of each
ZB-AAA GC column
(10 m 9 0.25 mm)
1
EZ:faast
TM demo video
and reference CD
1
User manual 1
Focus liners
TM 5
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and any unused amount discarded by the end of the
experiment.
General procedure
(1) Pipette 100 lL of the sample (serum, plasma or
other) and 100 lL of Reagent 1 [the norvaline
internal standard (NVIS)] into each sample prepa-
ration vial.
(2) Attach a sorbent tip to a 1.5 mL syringe and loosen
the syringe piston, then immerse the tip and let the
solution in the sample preparation vial pass through
the sorbent tip by slowly pulling back the syringe
piston in small steps (*1 min).
(3) Pipette 200 lL of Reagent 2 (wash solution) into the
same sample preparation vial and pass this solution
slowly through the sorbent tip and into the syringe
barrel. Drain the liquid from the sorbent bed by
pulling air through the sorbent tip, then detach the
latter and leave it in the sample preparation vial,
discarding the liquid accumulated in the syringe.
(4) Pipette 200 lL of the freshly prepared elution
medium in the same sample preparation vial.
(5) Pull back the piston of a 0.6 mL syringe halfway up
the barrel and attach the sorbent tip used in steps 2–
4. Wet the sorbent with the eluting medium; watch
as the liquid rises through the sorbent particles and
stop when the liquid reaches the ﬁlter plug in the
sorbent tip.
(6) Eject the liquid and sorbent particles out of the tip
and into the sample preparation vial. Repeat steps 5
and 6 until the sorbent particles in the tip are
expelled into the sample preparation vial. Only the
ﬁlter disc should remain in the empty tip.
(7) Using the adjustable Drummond Dialamatic Micro-
dispenser provided (The Drummond Scientiﬁc Co.,
Broomall, PA 19008, USA), transfer 50 lLo f
Reagent 4 (organic solution 1) into the sample
preparation vial, ensuring that the tip of the micro-
dispenser does not touch the inner wall of the vial.
(8) Emulsify the liquid in the vial by repeated vortexing
for *5–8 s, holding the vial straight and ﬁrmly
between ﬁngers. Allow the reaction to proceed for at
least 1 min. The emulsion will gradually separate
into two layers.
(9) Re-emulsify the liquids in the vial by vortexing
again for 5 s and allow the reaction to proceed for
another minute.
(10) Transfer with the microdispenser 100 lL of Reagent
5 (50 lL twice, for convenience) and mix for 5 s.
Allow the reaction to proceed for 1 more minute.
(11) Pipette 100 lL of Reagent 6 (not with the micro-
dispenser) and vortex for *5 s, then allow the
emulsion to separate into two layers. The upper layer
contains the derivatised AA to be analysed by GC.
Transfer part of this upper layer using a Pasteur
pipette into an autosampler (or other) vial for GC
injection.
(12) For standards for plasma AA, follow the whole
procedure using 100 lL each of standard 1 and
standard 2 (or your own standard) and 100 lL of the
NVIS. Each AA in all these standards is present at a
200 lM concentration.
GC conditions
We used a Clarus 500 GC (Perkin-Elmer) with a ﬂame-
ionisation detector (FID) and manual injection (1 lL)
using a 1 lL SGE syringe (SGE Europe Ltd., UK:
http://www.uk@sge.com). The column was a Zebron ZB-
AAA 10 m 9 0.25 mm capillary GC column. The column
oven temperature programme was: 32C per min from 110
to 320C. The FID detector temperature was 320C and
1 lL was injected at an injection temperature of 250C and
a split level of 1:2. The carrier gas was H2 at a pressure of
8 psi (a ﬂow rate of 1 mL/min). The ﬂow rate, pressure
setting and split ratios will need adjusting, depending on
GC instrument speciﬁcations, the carrier gas chosen and
other practical considerations.
Other analytical procedures
For total (free + albumin-bound) Trp analysis, we com-
pared this GC method with two other methods, namely the
standard ﬂuorimetric method of Denckla and Dewey
(1967), as modiﬁed by Bloxam and Warren (1974) and
detailed previously (Badawy and Evans 1976), and another
newly developed HPLC method for the separation and
quantiﬁcation of Trp and its kynurenine metabolites, details
of which will be published elsewhere (Badawy et al., in
preparation). Brieﬂy, we used a Perkin-Elmer LC200
quaternary system run isocratically using a reverse-phase
column (Synergi 4 l Fusion-RP80A, 250 9 4.6 mm) plus
guard column from Phenomenex Ltd., a mobile phase
mixture of methanol and sodium dihydrogen phosphate
buffer (27:73, by volume), ﬁnal pH 2.8, at a ﬂow rate of
1.2 ml/min at 37C, and a uv/vis detector (220 nm). The
same Total Chrome software used in the GC method also
controlled the data handling and processing. As the ﬂuo-
rimetric and HPLC methods involve initial acid
precipitation of proteins, the Trp measured is the total Trp.
Amino Acids (2008) 34:587–596 589
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(non-albumin-bound) state was determined separately by
the above ﬂuorimetric method in plasma ultraﬁltrates, as
described previously (Badawy et al. 2005).
AA recovery from plasma
Although the need for assessing recovery of AA during the
solid-phase extraction and derivatisation procedure is ren-
dered unnecessary by the use of the internal standard,
recovery of some amino acids of interest from plasma
samples was tested. Four different plasma samples were
spiked with three concentrations (50, 200 and 400 lM) of
the three AA of interest, namely Val, Leu and Ile. The
lowest concentration is equal to or less than the physio-
logical lower value, whereas the highest can be attained
and/or exceeded during the acute Trp depletion or loading
tests. The values obtained from each control (unspiked)
plasma sample were subtracted from those observed with
the corresponding spiked plasma and recorded as a per-
centage of the corresponding standard concentration of
each AA calibrant. Additionally, a recovery of the nor-
valine internal standard (NVIS; added at the 200 lM
concentration used routinely) was calculated from a pre-
vious experiment with 10 different plasma samples.
Sources of samples
The material for the analysis of which this GC method was
applied consisted of *1,000 plasma samples from 114
healthy, US subjects of both genders and diverse ethnicity,
undergoing an 8 h time-course pharmacokinetic study of
acute tryptophan depletion and loading tests, the pre-
liminary results of which have been reported in the abstract
form (Dougherty et al. 2005) and will be published in detail
elsewhere. Informed consent from the study subjects and
ethical approval from the Institutional Ethical Review
Board of the University of Texas Health Sciences Center at
Houston were obtained by the group leader Professor D. M.
Dougherty.
Results
Comments on and experience with the EZ:faast
TM
amino acid analysis kit
The kit is based on solid-phase extraction using a pro-
prietary cation-exchange mechanism. The acid solution of
the norvaline internal standard (Reagent 1) ensures that
plasma amino acids are in an anionic form suitable for
cationic binding, whereas the alkali of Reagent 3A of the
elution medium ensures that the AA cations are released
prior to derivatisation. We found the procedure simple and
enjoyable. Because of the toxicity of some components, the
procedure should be performed in a fume cabinet. To avoid
the occasional blockage of the sorbent tip by the buffy
layer, thawed plasma sample should be centrifuged at
*2,000–3,000g for 5 min and a clear portion is pipetted.
This is not necessary with freshly isolated plasma. Initially,
two plasma samples can be processed in 8–10 min, but,
with experience, one person can process six samples in
*15 min.
GC Proﬁles of standards and plasma samples
Figure 1 illustrates a number of GC proﬁles. The ﬁrst (a) is
of a 6-component standard prepared in our laboratory
containing a 200 lM concentration each of Trp, Tyr, Phe,
Val, Leu and Ile, to which the norvaline internal standard
(NVIS) was added, whereas the second (b) is of the Phe-
nomenex standards 1 and 2 containing the above 6 and 20
other amino acids and the NVIS, also at 200 lM each. The
order of elution of 25 of these 26 AA (plus the NVIS) is as
follows: Ala, Sar, Gly, ABA, Val, BAIB, NVIS, Leu,
ALeu, Ile, Thr, Ser, Pro, Asn, Asp, Met, Hyp, Glu, Phe,
AAA, Gln, Orn, Lys, His, Tyr and Trp. Although its peak
follows that of Trp, the 26th AA (cystine) is not deﬁned
here. As shown, the run took less than 7 min. Three plasma
proﬁles are also illustrated in Fig. 1, which shows clearly
the differences in the Trp peaks between the normal fasting
plasma sample (c) and those obtained from two subjects
undergoing, respectively, acute Trp depletion (d) and
loading (e) tests. In both these two latter tests, a mixture of
15 amino acids was consumed, which was rich in the 5 Trp
competitors (Val, Leu, Ile, Phe and Tyr), but with Trp
either omitted (depletion) or added (loading), hence: (1) the
differences in the Trp peaks; (2) the larger peaks of the 3
branched-chain amino acids Val, Leu and Ile and (3) of 10
of the other 12 amino acids added (Ala, Gly, Thr, Ser, Pro,
Met, Phe, Lys, His and Tyr), compared with those in the
fasting sample (c). The other two amino acids added to the
above mixture (namely Arg and Cys) could not be identi-
ﬁed because of their absence from the standards (see
below).
Validation of the method
Detection and its limit
We have conﬁrmed the manufacturer’s statement that the
limit of detection for most AA is 1 nmol/ ml (1 lM) and
590 Amino Acids (2008) 34:587–596
123Fig. 1 Gas-chromatographic
proﬁles of: a our laboratory
standard mixture of six amino
acids (Val, Leu, Ile, Phe, Tyr
and Trp); b the Phenomenex
Standards 1 and 2 containing
23 plus 3 amino acids,
respectively; c fasting plasma;
d plasma of a subject 4 h after
consumption of a tryptophan-
free amino acid formulation;
e plasma of a subject 4 h after
consumption of a tryptophan-
loaded amino acid formulation.
The standard amino acids in
(a) and (b) are all at 200 lM
concentration each. All
standards and plasma samples
included the norvaline internal
standard (NVIS), also at
200 lM, whose peak appears
immediately after that of Val.
For the elution order of all AA
in (b), see the ‘‘Results’’ section
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and Thr, which were not detectable at this latter concen-
tration. Additionally, bAIB (b-aminoisobutyric acid) was
not detectable at 0.5 or 1 lM. By contrast, taurine was not
detectable by this method, as it is not retained due to its
strong sulphonic acid group (pKa 1.9). Also, the inhibitory
neurotransmitter amino acid GABA (c-aminobutyric acid),
which is of interest in epilepsy and alcoholism research,
cannot be determined in plasma by this method, because it
co-elutes with serine. However, the GABA plasma levels
(0.15 lM determined by HPLC, see Cowley et al. 1996)
are much smaller than those of serine to present a signiﬁ-
cant interference in Ser analysis. As stated above, Arg and
Cys could not be identiﬁed by this GC-FID procedure. The
kit manufacturer does, however, provide chromatographic
information on these two and other AA, suggesting that: (1)
Cys migrates after AAA (a-aminoadipic acid) and before
Gln; (2) the derivative of Arg is not volatile, hence its
determination is achieved with the LC-MS kit; (3) these
and all other AA not mentioned so far (e.g. citrulline,
1- and 3-methylhistidines and other sulphur-containing
AA) can be measured using the kit for LC-MS.
Precision
The intra-assay coefﬁcient of variation (CV) was tested by
injection of one derivatised sample of the Phenomenex
standards 1 and 2 (containing 200 lM of each AA) ten
times in succession. Inter-assay CV’s were determined
from daily GC injections of 25 different calibration mix-
tures of standards 1 and 2 (also containing 200 lMA A
concentrations) for 25 days. The results, limited to our six
amino acids of special interest, are shown in Table 2.
As shown, all CVs were \10%, in agreement with the
manufacturer’s data for most AA.
Recovery
AA recovery from plasma was assessed for three AA of
interest, whose levels vary widely during the acute Trp
depletion and loading tests. As shown in Table 3, full or
almost full recoveries were observed for all three AA at all
three concentrations, with only one exception (Leu at
50 lM, which is below its normal range). The recovery of
the NVIS, which is corrected by the software, was also
good (96%).
Comparison with other methods of tryptophan
determination
We have compared our GC procedure for plasma total Trp
determination with two other methods: the standard ﬂuo-
rimetric method of Denckla and Dewey (1967) and an
HPLC procedure, developed in our laboratory, details of
which will be reported elsewhere. Both methods also
measure total Trp, since they involve prior acid-precipita-
tion and removal of proteins. The opportunity of comparing
low, high and normal Trp values was provided by our study
of the acute Trp depletion and loading tests, in which
extreme decreases and increases in plasma total [Trp],
respectively, are induced. The results showed highly sig-
niﬁcant ((P\0.0001) linear correlations (r = 0.9784–
0.9907) between the Trp values determined by GC and
HPLC for both the low-normal and normal-high ranges
(data not shown) and between the Trp values determined
by GC and the standard ﬂuorimetric method (r = 0.9774)
(Fig. 2). These highly signiﬁcant correlations are not sur-
prising, since they illustrate a comparison of results by two
methods measuring the same parameter (Jones and Payne
1997). Bland and Altman (1986) plots were then drawn for
the means of each two methods and the differences
between them. No absolute or proportionate bias could be
detected, as nearly a half of all points lay on the 45 line
with the other half equally distributed above and below this
line. In addition, the results in Fig. 2 further conﬁrm that
Table 2 Intra-assay and Inter-assay coefﬁcients of variation for
seven amino acids
Amino acid Intra-assay CV (%)
(n = 10)
Inter-assay CV (%)
(n = 25)
Val 1.9 7.8
Leu 2.3 3.8
Ile 1.5 5.6
Phe 3.8 6.3
Tyr 6.2 6.7
Trp 4.2 9.7
NVIS 4.2 8.2
Table 3 Recovery of some amino acids from plasma samples
Concentration added (lM) to plasma
50 200 400
Recovery (%)
Val 108 ± 7 105 ± 6 118 ± 5
Leu 89 ± 09 8 ± 1 100 ± 1
Ile 104 ± 59 9 ± 3 104 ± 2
Values are means ± SEM for three to four determinations using
different plasma samples for each concentration. The NVIS recovery
from ten plasmas was 96 ± 3
592 Amino Acids (2008) 34:587–596
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shown corresponded to those obtained by ﬂuorimetry,
which involves acid precipitation of, and release of Trp
from, proteins.
Derivatised sample stability
The manufacturer states that the chloroformate-derivatising
agent derivatises both the amino and carboxylic acid
groups and that the resultant derivatives are stable for
1 day at room temperature and for several days at 4C. We
have not tested stability at room temperature, but can
conﬁrm stability at -24 to -32C for up to 48 h (the
longest duration tested). This could be helpful if, for any
reason, a stored calibrant (reference) has to be used again 1
or 2 days later, although we recommend the processing of
the calibrant reference in each experiment.
Linearity
This was tested using both the Phenomenex Standards 1
and 2 and our own six-component standard (all at 200 lM
AA concentration each). Linearity was established for the
1–200 lM range for Val, Leu, Ile and Phe, and for the
2–200 lM range for Tyr and Trp.
Normal values and other results
The mean plasma values ± SD for our six amino acids of
special interest in fasting control adult subjects are shown
in Table 4, which includes a comparison with some pre-
viously published plasma values (Armstrong and Stave
1973). It is clear that our means for most of the above AA
are similar, but that our sample shows a larger variation.
The close agreement in the [Trp] values between our GC
procedure and the cation-exchange method used by the
above authors further conﬁrms that the solid-phase parti-
cles bind both the free and albumin-bound Trp fractions in
plasma, thus measuring total [Trp]. This is further con-
ﬁrmed by the close correlation and agreement between the
GC results and those obtained by ﬂuorimetry, which also
measures total Trp. It should be emphasised here that a
strict comparison between our GC and the cation-exchange
method used by the above authors is not possible, since
other experimental differences may exist, including popu-
lation differences. The results in Table 5 (derived mostly
from the data in Table 4) give for the ﬁrst time normal
plasma values in 114 healthy, US subjects of parameters of
Trp and Tyr availability to the brain, which are the most
accurate predictors of the rates of central synthesis of
serotonin and dopamine (and hence noradrenaline),
respectively. In addition to the above results and the three
plasma proﬁles in Fig. 1, the time course of changes in
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Fig. 2 Comparison of plasma total tryptophan determination by gas
chromatography (GC) and ﬂuorimetry in 16 samples taken from
subjects in the fasting and non-fasting states
Table 4 Fasting normal values for plasma tryptophan and its
competitors
Amino acid Mean ± SD Mean ± SD*
Ile 59 ± 23 84 ± 18
Leu 109 ± 33 160 ± 27
Phe 78 ± 27 65 ± 9
Trp 63 ± 20 60 ± 15
Tyr 59 ± 30 72 ± 15
Val 246 ± 53 252 ± 37
Values are in lmol/L for plasma samples from 114 adult, US subjects
analysed by GC (our results) and for those analysed by *cation-
exchange from 91 subjects in the study by Armstrong and Stave
(1973)
Table 5 Normal plasma values for parameters of tryptophan and
tyrosine availability to the brain in 114 healthy, US subjects
Parameter Mean ± SD Range
[Free Trp] (lM) 6.4 ± 0.3 1.5–14.9
[Total Trp] (lM) 63 ± 20 27–127
[CAA] (lM) 552 ± 114 317–907
[Free Trp]/[CAA] ratio 0.0125 ± 0.0056 0.0070–0.0272
[Total Trp]/[CAA] ratio 0.117 ± 0.036 0.050–0.236
[Phe + Tyr] (lM) 138 ± 49 61–464
[LNAA + Trp] (lM) 478 ± 100 272–850
[Phe + Tyr]/[LNAA + Trp] ratio 0.2940 ± 0.1029 0.1482–0.9261
[Free Trp] was determined ﬂuorimetrically in ultraﬁltrates, whereas
those of all other amino acids including total Trp were determined by
GC, from which ratios were calculated. Apart from [Free Trp], the
above data are derived from those in Table 4. CAA is the sum of Val,
Leu, Ile, Phe and Tyr, whereas LNAA are the sum of Val, Leu and Ile
Amino Acids (2008) 34:587–596 593
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oral consumption of a 100 g dose of the acute Trp deple-
tion test formulation by 24 normal subjects is illustrated in
Fig. 3, which shows, as expected, the decrease in [Trp] and
the varying levels of rises in the ﬁve competitors reﬂecting
their different contents in the formulation (see Badawy
et al. 2007).
Discussion
In the present work, we have successfully applied the
Phenomenex EZ:faast
TM amino acid analysis kit for gas-
chromatographic (GC) determination of plasma amino
acid concentrations. In our experience, this is a rapid,
simple, elegant and sensitive method possessing two
particularly important new features. The ﬁrst is that it
does not require prior removal of proteins, urea or other
interfering substances, as it uses solid-phase extraction,
thus avoiding lengthy sample preparative (including der-
ivatisation) procedures and the associated losses due to
instability and poor recoveries of some amino acids
(Walker and Mills 1995). Secondly, coupled with suitable
data handling and processing software (the Perkin-Elmer
Total Chrome system), it can deliver an almost complete
amino acid proﬁle for the reference and ﬁrst plasma
sample in \30 min from start to ﬁnish. This is because
the 7-min GC run per plasma sample is preceded by a
short sample preparation time of 8–10 min per two
samples, and *15 min for six samples. Other advantages
include: (1) freedom from interference by drugs or their
metabolites; (2) stability of reagents for 12 months; (3)
rapid (1 min) derivatisation in aqueous solution of both
the NH2 and COOH groups at room temperature; (4)
stability of the derivatised AA for several hours at room
temperature and for days at 4C or below. All these
advantages coupled with the greater sensitivity, resolu-
tion, sharpness and reproducibility of its peaks combine to
make GC the ideal technique for amino acid analysis in
the clinical or research laboratory. The result is a dra-
matic reduction in manpower hours and a simultaneous
improvement in analytical performance, hitherto unseen
with other analytical techniques, including existing GC
methods with an average analysis time of 30 min (Walker
and Mills 1995), which far outweigh the not excessive
cost of equipment. Although different versions of the kit
can be used with a GC with different detector types (FID,
NPD, MS) or with liquid chromatography (LC-MS), our
experience with the cheapest system (GC-FID), using the
corresponding kit, which is the fastest within this family
of kits (7 min run time versus 12 min with LC-MS), was
very satisfactory, even with manual injection. A refrig-
erated liquid autosampler would enable overnight running
of samples at the rate of 8 samples/h, an eightfold
advance over HPLC (Walker and Mills 1995). Only such
a speed can meet emergency requests and the demands of
a high throughput clinical or research laboratory.
The only disadvantage of the GC family of kits is its
inability to determine some amino acids, namely Arg, Cit,
1- and 3-methylhistidines, Cys and some other sulphur-
containing AA. All these and other AA and their deriva-
tives (up to 50 in total), can, however, be determined using
the kit for LC-MS. Thus, depending on the requirements of,
and the availability of equipment in, the analytical labo-
ratory, the appropriate kit can be used for various clinical
and research purposes.
We have conﬁrmed the manufacturer’s data on the sta-
bility of the chloroformate derivatives and the limits of
detection of the various AA and have additionally exam-
ined other aspects of method validation, including linearity,
precision, recovery from plasma, comparison with other
methods (using Trp only) and comparison of normal fasting
plasma values for six AA with corresponding values in
literature using cation-exchange chromatography, all of
which had satisfactory outcomes.
We have not examined the chromatographic behaviour
of the six urine-speciﬁc AA and their derivatives, and it
therefore remains for others to include these in future
assessments. This method is not suitable for the analysis
of plasma taurine or GABA; the former is not retained
due to its strong sulphonic acid group, whereas the latter
co-elutes with serine, but this is not a problem, given the
minimal contribution of physiological concentrations of
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Fig. 3 Time course of changes in concentrations of some amino
acids following consumption of a 100 g dose of the acute tryptophan
depletion test formulation. Plasma was analysed before and at hourly
intervals for 7 h after oral consumption of the formulation for Trp
(ﬁlled circle), Phe (ﬁlled inverted triangle),Tyr (open circle), Ile
(open square), Leu (ﬁlled square) and Val (open inverted triangle).
Values are means ± SEM (bars) for n = 24 subjects
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123this neurotransmitter (Cowley et al. 1996) to the serine
peak.
Although we placed a special emphasis on analysis of
Trp and other amino acids, which compete with it for entry
into the brain (Val, Leu, Ile, Phe and Tyr), by a happy
coincidence, this particular AA group is also of special
interest in phenylketonurea (PKU), tyrosinaemia and
maple-syrup disease (MSD) research and clinical man-
agement. This method will therefore be of additional
special interest to those working in these areas. In this latter
respect, another GC method, also using solid-phase
extraction, but after derivatisation of amino acids suitably
extracted from neonatal blood samples, has been published
by Deng et al. (2004), using GC-MS, which involved a
*1 h AA extraction from blood spots, twice as long der-
ivatisation and processing time (15 min) and twice as long
GC run time (*14 min). Nevertheless, though slower than
our Phenomenex, this latter method further demonstrates
the faster performance of GC over other chromatographic
procedures.
As we have limited our comparison of this GC method
with other methods only for plasma Trp analysis, we could
not provide direct comparisons for other AA. However, and
despite the fact that different laboratories have different
normal values and ranges depending on various factors,
indirectly, this GC method gives values for the 5 Trp
competitors Val, Leu, Ile, Phe and Tyr (and also Trp) not
dissimilar to those in the literature (Table 4).
We have provided in Table 5 the normal values of 114
healthy, US subjects for parameters of availability to the
brain of the amino acid precursors of serotonin (Trp) and
dopamine and noradrenaline (Phe and Tyr), which should
make a useful reference in future research in this area.
Previously, we had provided corresponding data for serum
parameters of Trp availability to the brain and established
criteria for assessing the serotonin-biosynthetic status using
values from 42 fasting, healthy, adult UK subjects (Badawy
et al. 2005). Determination of these parameters is important
in assessing the serotonin and catecholamine status in
normal subjects and in those with behavioural disorders
(Sheehan et al. 1996; Reilly et al. 1997; Badawy et al.
2005).
In summary, our informal evaluation of the Phenomenex
EZ:faast procedure for analysis of circulating amino acids
using the kit for GC-FID has demonstrated the advantages
of this new method. The versatility of the procedure
through availability of various kits will enable AA analysts
to select the most suitable of the kits for their purposes. We
believe that our study will raise the awareness, in AA
analysts and researchers, of this new procedure and will
lead to further assessments and its eventual adoption as the
method of choice in clinical and research laboratories.
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